US EditionPublished • loading... • Updated
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives $16.25 Average Target Price from Brokerages
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives $16.25 Average Target Price from Brokerages
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the nine ratings firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have given a buy recommendation to […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
